InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by WHITNELL JEFFREY A, Director. Officer active across 1 companies, notably Elite Pharmaceuticals INC. Cumulatively, 2 disclosures have been recorded. The latest transaction was filed on 30 June 2021 — Attribution. Regulator: SEC (Form 4). All data is free.
Declarations2 total
€16,877295,570 shares@ €0.0571100.0% of flow
Common Stock
SEC:0001324222-21-000003·
€16,877295,570 shares@ €0.05710.0036% mcap50.0% of flow
Common Stock
SEC:0001324222-21-000003:0·
2 of 2 declarations
About WHITNELL JEFFREY A
Jeffrey A. Whitnell is a Director at ELITE PHARMACEUTICALS INC /NV/. In this role, he contributes to the governance of the company and strategic decision-making. Jeffrey brings expertise in the pharmaceutical sector, which is essential for guiding product development and regulatory compliance initiatives. His commitment to innovation and quality is crucial for the long-term success of the company.
